References - Cancer Nanotheranostics - page 110

Pan Y, Jia TT, Zhang Y, Zhang K, Zhang R, Li JM, Wang LN (2012) MS2 VLP-based deliv-
ery of microRNA-146a inhibits autoantibody production in lupus-prone mice. Int J Nanomed
7:5957-5967
Pardeike J, Hommoss A, Müller RH (2009) Lipid nanoparticles (SLN, NLC) in cosmetic and
pharmaceutical dermal products. Int J Pharm 366:170-184
Parvin N, Mandal TK, Roy P (2013) Polyelectrolyte carbon quantum-dots: new player as a non-
invasive imaging probe in Drosophila. J Nanosci Nanotechnol 13:6499-6505
Patel AR, Chougule MB, Lim E, Francis KP, Safe S, Singh M (2014) Theranostic tumor homing
nanocarriers for the treatment of lung cancer. Nanomed Nanotechnol Biol Med 10:1053-1063
Patel NR, Pattni BS, Abouzeid AH, Torchilin VP (2013) Nanopreparations to overcome multi-
drug resistance in cancer. Adv Drug Deliv Rev 65:1748-1762
Patil YB, Swaminathan SK, Sadhukha T, Ma L, Panyam J (2010) The use of nanoparticle-
mediated targeted gene silencing and drug delivery to overcome tumor drug resistance.
Biomaterials 31(2):358-365
Patri AK, Kukowska-Latallo JF, Baker JR Jr (2005) Targeted drug delivery with dendrimers:
comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclu-
sion complex. Adv Drug Deliv Rev 57:2203-2214
Patri AK, Majoros IJ, Baker JR (2002) Dendritic polymer macromolecular carriers for drug
delivery. Curr Opin Chem Biol 6:466-471
Patro NM, Devi K, Pai RS, Suresh S (2013) Evaluation of bioavailability, efficacy, and safety
profile of doxorubicin-loaded solid lipid nanoparticles. J Nanopart Res 15:2124-2131
Pecot CV, Calin GA, Coleman RL, Berestein GL, Sood AK (2011) RNA interference in the
clinic: challenges and future directions. Nat Rev Cancer 11:59-67
Peer D, Jeffrey M, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R (2007) Nanocarriers
as an emerging platform for cancer therapy. Nat Nanotechnol 2:751-760
Peira E, Marzola P, Podio V, Aime S, Sbarbati A, Gasco MR (2003) In vitro and in vivo study of
solid lipid nanoparticles loaded with superparamagnetic iron oxide. J Drug Target 11:19-24
Peng CL, Shih YH, Lee PC, Hsieh TM, Luo TY, Shieh MJ (2011) Multimodal image-guided
photothermal therapy mediated by 188 Re-labeled micelles containing a cyanine-type photosen-
sitizer. ACS Nano 5(7):5594-5607
Peng H, Travas-Sejdic J (2009) Simple aqueous solution route to luminescent carbogenic dots
from carbohydrates. Chem Mater 21:5563-5565
Pereira PMR, Carvalho JJ, Silva S, Cavaleiro JAS, Schneider RJ, Fernandes R, Tomé JPC (2014)
Porphyrin conjugated with serum albumins and monoclonal antibodies boosts efficiency in
targeted destruction of human bladder cancer cells. Org Biomol Chem 12:1804-1811
Piao L, Zhang M, Datta J, Xie X, Su T, Li H, Teknos TN, Pan Q (2012) Lipid-based nanoparticle
delivery of pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carci-
noma. Mol Ther 20:1261-1269
Pluen A, Boucher Y, Ramanujan S, McKee TD, Gohongi T, Tomaso E, Brown EB, Izumi Y,
Campbell RB, Berk DA et al (2001) Role of tumor host interactions in interstitial diffusion
of macromolecules: cranial vs subcutaneous tumors. Proc Natl Acad Sci USA 98:4628-4633
Pokorski JK, Hovlid ML, Finn MG (2011) Cell targeting with hybrid Qbeta virus-like particles
displaying epidermal growth factor. Chembiochem 12:2441-2447
Puglia C, Offerta A, Rizza L, Zingale G, Bonina F, Ronsisvalle S (2013) Optimization of
curcumin loaded lipid nanoparticles formulated using high shear homogenization (HSH) and
ultrasonication (US) methods. J Nanosci Nanotechnol 13:6888-6893
Qi C, Chen Y, Jing QZ, Wang XG (2011) Preparation and characterization of catalase-loaded
solid lipid nanoparticles protecting enzyme against proteolysis. Int J Mol Sci 12:4282-4293
Qian C, Decker EA, Xiao H, McClements DJ (2013) Impact of lipid nanoparticle physical
state on particle aggregation and ʲ -carotene degradation: potential limitations of solid lipid
nanoparticles. Food Res Int 52:342-349
Quan Q, Xie J, Gao H, Yang M, Zhang F, Liu G, Lin X, Wang A, Eden HS, Lee S, Zhang G,
Chen X (2011) HSA coated iron oxide nanoparticles as drug delivery vehicles for cancer ther-
apy. Mol Pharm 8:1669-1676